Back to search results

An Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Carcinoma, Non-Small-Cell Lung Cancer (NSCLC)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Mayo Clinic, Rochester, Minnesota, United States

    Contact: Study coordinator (Pierson Karlyn) · pierson.karlyn@mayo.edu · 877-526-9172
    Contact: Principal Investigator (Janani S Reisenauer, MD)

  • Toronto General Hospital, Toronto, Ontario, Canada

    Contact: Study coordinator (Kazuhiro Yasufuku / Principle Investigator) · kazuhiro.yasufuku@uhn.ca · 416-340-4798
Study leads

  • Kazuhiro Yasufuku MD, PhD, FRCSC

    Principal Investigator

    University Health Network, Toronto

  • Janani S Reisenauer, MD

    Principal Investigator

    Mayo Clinic

View source on ClinicalTrials.gov(opens in a new tab)